Kelly Wilson
Director de Operaciones en BIOSTAX CORP. .
Fortuna: 733 599 $ al 30/04/2024
Perfil
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BIOSTAX CORP
18.64% | 28/03/2024 | 15 608 498 ( 18.64% ) | 733 599 $ | 30/04/2024 |
Cargos activos de Kelly Wilson
Empresas | Cargo | Inicio |
---|---|---|
BIOSTAX CORP. | Director de Operaciones | 01/08/2022 |
Forte Animal Health, Inc. | Director/Miembro de la Junta | 01/12/2020 |
Antiguos cargos conocidos de Kelly Wilson.
Empresas | Cargo | Fin |
---|---|---|
BIOSTAX CORP. | Director Ejecutivo | 25/07/2023 |
BIOSTAX CORP. | Director Técnico/Científico/I+D | 01/04/2020 |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Director Técnico/Científico/I+D | 01/04/2020 |
Formación de Kelly Wilson.
University of Central Florida | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOSTAX CORP. | Health Technology |
Empresas privadas | 2 |
---|---|
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Health Technology |
Forte Animal Health, Inc. |
- Bolsa de valores
- Insiders
- Kelly Wilson